2003
DOI: 10.1007/bf03019384
|View full text |Cite
|
Sign up to set email alerts
|

Inhaled nitric oxide in 2003: a review of its mechanisms of action

Abstract: P Pu ur rp po os se e: : To review the pulmonary and systemic effects of endogenous nitric oxide and inhaled nitric oxide administered to patients.S So ou ur rc ce e: : A systematic search for experimental data, human case reports, and randomized clinical trials since 1980, the year of discovery of endothelium-derived relaxing factor. P Pr ri in nc ci ip pa al l f fi in nd di in ng gs s: : Nitric oxide has pulmonary and systemic effects. Inhaled nitric oxide not only causes selective pulmonary vasodilation but… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(36 citation statements)
references
References 88 publications
(79 reference statements)
0
35
0
1
Order By: Relevance
“…Also, low INO doses seem to be beneficial, while higher doses may contribute to inflammatory injury. 39 It is therefore possible that the early application of low dose INO (5 ppm) may have attenuated oxidative lung injury in our model.…”
Section: Discussionmentioning
confidence: 94%
“…Also, low INO doses seem to be beneficial, while higher doses may contribute to inflammatory injury. 39 It is therefore possible that the early application of low dose INO (5 ppm) may have attenuated oxidative lung injury in our model.…”
Section: Discussionmentioning
confidence: 94%
“…Hemoglobin is transformed to methemoglobin, which is secondarily reduced to hemoglobin by methemoglobin reductase. Although NO has no systemic hemodynamic effects, it does have extrapulmonary activity (Wang et al, 2003). That is, it interferes with platelet and leukocyte functions, fibrinolysis, and reperfusion injury by inhibiting expression of adhesion molecules at leukocyte surfaces and by activation of sCG, which lead to a rapid increase in platelet cGMP and inhibition of platelet aggregation.…”
Section: Inhalable Vasodilatorsmentioning
confidence: 99%
“…NO, produced by nNOS and eNOS in nanomolar concentration, play an important role as a neurotransmitter and vasodilator. However, overproduction of NO, mediated by iNOS, intimately correlated with the pathological conditions in inflammation related diseases (Wang et al, 2003). COX (cyclooxygenase), another key enzyme in inflammation, is the rate-limiting enzyme that catalyzes the formation of PGs from arachidonic acid.…”
Section: Introductionmentioning
confidence: 99%